This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

reputable news agency

proofread

Dexmedetomidine cuts incidence of postpartum depression after C-section

Dexmedetomidine cuts incidence of postpartum depression after C-section

For women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a study published online Jan. 25 in JAMA Network Open.

Yingyong Zhou, Ph.D., from The Third Xiangya Hospital of Central South University in Changsha, China, and colleagues conducted a involving 338 women who screened positive for prenatal depression and were scheduled for elective cesarean delivery at two hospitals to assess the efficacy and safety of dexmedetomidine for prevention of PPD. A total of 338 participants were randomly assigned in a 1:1 ratio to receive dexmedetomidine or saline, infused for 10 minutes after delivery. After infusion, sufentanil or dexmedetomidine plus sufentanil was administered for 48 hours in the control and dexmedetomidine groups, respectively.

The researchers found that the incidence of positive PPD screening at seven and 42 days postpartum was significantly reduced in the dexmedetomidine group versus the (day 7: 12.6 versus 32.1%; risk ratio, 0.39; day 42: 11.4 versus 30.3%; risk ratio, 0.38). No significant difference was seen between the groups in terms of adverse events, but an increased incidence of hypotension was seen in the dexmedetomidine group (18.3 versus 9.5%; risk ratio, 2.15).

"Preventive administration of dexmedetomidine in the early postpartum period reduced the incidence of positive PPD screening, reduced , improved sleep quality, and maintained a favorable safety profile," the authors write. "Its may be related to brain-derived upregulation and/or downregulation of pro-brain-derived neurotrophic factor."

More information: Yingyong Zhou et al, Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression, JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2023.53252

Journal information: JAMA Network Open

2024 HealthDay. All rights reserved.

Citation: Dexmedetomidine cuts incidence of postpartum depression after C-section (2024, January 26) retrieved 14 July 2024 from https://medicalxpress.com/news/2024-01-dexmedetomidine-incidence-postpartum-depression-section.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Dexmedetomidine cuts perioperative respiratory adverse events in tonsillectomy

0 shares

Feedback to editors